Loading
Life sciences · Journal article
Microplastics · November 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
This review critically examines current evidence regarding the ability of microplastics and nanoplastics (MNPs) to interact with and traverse the blood–brain barrier (BBB), their neurotoxic effects, and their potential relevance to pathways associated with neurodegenerative diseases. Experimental evidence indicates that MNPs can reach neural tissues and disrupt BBB integrity, with transport and biological effects influenced by particle size, shape, surface properties, and chemical composition. In vitro and animal studies demonstrate that MNP exposure can induce oxidative stress, mitochondrial dysfunction, neuroinflammation, BBB impairment, and altered proteostasis. These responses overlap with mechanisms implicated in Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Emerging human studies have also detected plastic particles in postmortem brain tissue and cerebrospinal fluid, raising concerns regarding potential CNS exposure. However, human evidence remains limited, and the observed molecular and cellular responses are not specific to MNP exposure or individual neurodegenerative diseases. Current evidence supports the biological plausibility of MNP-induced neurotoxicity but does not establish a causal relationship between MNP exposure and human neurodegenerative disease. Oxidative stress, inflammation, mitochondrial dysfunction and impaired proteostasis are shared responses across numerous environmental toxicants and pathological conditions. Therefore, associations between MNP exposure and AD, PD or ALS should be interpreted cautiously. Standardized and contamination-controlled analytical methods, environmentally relevant exposure models, and longitudinal epidemiological studies are required to determine whether chronic MNP exposure represents an independent neurological risk factor or modifies existing vulnerability to neurodegenerative disease.